Cargando…
Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort
The World Health Organization recently defined hypertension and type 2 diabetes (T2D) as modifiable comorbidities leading to dementia and Alzheimer’s disease. In the United States (US), hypertension and T2D are health disparities, with higher prevalence seen for Black and Hispanic minority groups co...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672061/ https://www.ncbi.nlm.nih.gov/pubmed/36396674 http://dx.doi.org/10.1038/s41598-022-23353-z |
_version_ | 1784832674956836864 |
---|---|
author | Nagar, Shashwat Deepali Pemu, Priscilla Qian, Jun Boerwinkle, Eric Cicek, Mine Clark, Cheryl R. Cohn, Elizabeth Gebo, Kelly Loperena, Roxana Mayo, Kelsey Mockrin, Stephen Ohno-Machado, Lucila Ramirez, Andrea H. Schully, Sheri Able, Ashley Green, Ashley Zuchner, Stephan Jordan, I. King Meller, Robert |
author_facet | Nagar, Shashwat Deepali Pemu, Priscilla Qian, Jun Boerwinkle, Eric Cicek, Mine Clark, Cheryl R. Cohn, Elizabeth Gebo, Kelly Loperena, Roxana Mayo, Kelsey Mockrin, Stephen Ohno-Machado, Lucila Ramirez, Andrea H. Schully, Sheri Able, Ashley Green, Ashley Zuchner, Stephan Jordan, I. King Meller, Robert |
author_sort | Nagar, Shashwat Deepali |
collection | PubMed |
description | The World Health Organization recently defined hypertension and type 2 diabetes (T2D) as modifiable comorbidities leading to dementia and Alzheimer’s disease. In the United States (US), hypertension and T2D are health disparities, with higher prevalence seen for Black and Hispanic minority groups compared to the majority White population. We hypothesized that elevated prevalence of hypertension and T2D risk factors in Black and Hispanic groups may be associated with dementia disparities. We interrogated this hypothesis using a cross-sectional analysis of participant data from the All of Us (AoU) Research Program, a large observational cohort study of US residents. The specific objectives of our study were: (1) to compare the prevalence of dementia, hypertension, and T2D in the AoU cohort to previously reported prevalence values for the US population, (2) to investigate the association of hypertension, T2D, and race/ethnicity with dementia, and (3) to investigate whether race/ethnicity modify the association of hypertension and T2D with dementia. AoU participants were recruited from 2018 to 2019 as part of the initial project cohort (R2019Q4R3). Participants aged 40–80 with electronic health records and demographic data (age, sex, race, and ethnicity) were included for analysis, yielding a final cohort of 125,637 individuals. AoU participants show similar prevalence of hypertension (32.1%) and T2D (13.9%) compared to the US population (32.0% and 10.5%, respectively); however, the prevalence of dementia for AoU participants (0.44%) is an order of magnitude lower than seen for the US population (5%). AoU participants with dementia show a higher prevalence of hypertension (81.6% vs. 31.9%) and T2D (45.9% vs. 11.4%) compared to non-dementia participants. Dominance analysis of a multivariable logistic regression model with dementia as the outcome shows that hypertension, age, and T2D have the strongest associations with dementia. Hispanic was the only race/ethnicity group that showed a significant association with dementia, and the association of sex with dementia was non-significant. The association of T2D with dementia is likely explained by concurrent hypertension, since > 90% of participants with T2D also had hypertension. Black race and Hispanic ethnicity interact with hypertension, but not T2D, to increase the odds of dementia. This study underscores the utility of the AoU participant cohort to study disease prevalence and risk factors. We do notice a lower participation of aged minorities and participants with dementia, revealing an opportunity for targeted engagement. Our results indicate that targeting hypertension should be a priority for risk factor modifications to reduce dementia incidence. |
format | Online Article Text |
id | pubmed-9672061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96720612022-11-19 Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort Nagar, Shashwat Deepali Pemu, Priscilla Qian, Jun Boerwinkle, Eric Cicek, Mine Clark, Cheryl R. Cohn, Elizabeth Gebo, Kelly Loperena, Roxana Mayo, Kelsey Mockrin, Stephen Ohno-Machado, Lucila Ramirez, Andrea H. Schully, Sheri Able, Ashley Green, Ashley Zuchner, Stephan Jordan, I. King Meller, Robert Sci Rep Article The World Health Organization recently defined hypertension and type 2 diabetes (T2D) as modifiable comorbidities leading to dementia and Alzheimer’s disease. In the United States (US), hypertension and T2D are health disparities, with higher prevalence seen for Black and Hispanic minority groups compared to the majority White population. We hypothesized that elevated prevalence of hypertension and T2D risk factors in Black and Hispanic groups may be associated with dementia disparities. We interrogated this hypothesis using a cross-sectional analysis of participant data from the All of Us (AoU) Research Program, a large observational cohort study of US residents. The specific objectives of our study were: (1) to compare the prevalence of dementia, hypertension, and T2D in the AoU cohort to previously reported prevalence values for the US population, (2) to investigate the association of hypertension, T2D, and race/ethnicity with dementia, and (3) to investigate whether race/ethnicity modify the association of hypertension and T2D with dementia. AoU participants were recruited from 2018 to 2019 as part of the initial project cohort (R2019Q4R3). Participants aged 40–80 with electronic health records and demographic data (age, sex, race, and ethnicity) were included for analysis, yielding a final cohort of 125,637 individuals. AoU participants show similar prevalence of hypertension (32.1%) and T2D (13.9%) compared to the US population (32.0% and 10.5%, respectively); however, the prevalence of dementia for AoU participants (0.44%) is an order of magnitude lower than seen for the US population (5%). AoU participants with dementia show a higher prevalence of hypertension (81.6% vs. 31.9%) and T2D (45.9% vs. 11.4%) compared to non-dementia participants. Dominance analysis of a multivariable logistic regression model with dementia as the outcome shows that hypertension, age, and T2D have the strongest associations with dementia. Hispanic was the only race/ethnicity group that showed a significant association with dementia, and the association of sex with dementia was non-significant. The association of T2D with dementia is likely explained by concurrent hypertension, since > 90% of participants with T2D also had hypertension. Black race and Hispanic ethnicity interact with hypertension, but not T2D, to increase the odds of dementia. This study underscores the utility of the AoU participant cohort to study disease prevalence and risk factors. We do notice a lower participation of aged minorities and participants with dementia, revealing an opportunity for targeted engagement. Our results indicate that targeting hypertension should be a priority for risk factor modifications to reduce dementia incidence. Nature Publishing Group UK 2022-11-17 /pmc/articles/PMC9672061/ /pubmed/36396674 http://dx.doi.org/10.1038/s41598-022-23353-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Nagar, Shashwat Deepali Pemu, Priscilla Qian, Jun Boerwinkle, Eric Cicek, Mine Clark, Cheryl R. Cohn, Elizabeth Gebo, Kelly Loperena, Roxana Mayo, Kelsey Mockrin, Stephen Ohno-Machado, Lucila Ramirez, Andrea H. Schully, Sheri Able, Ashley Green, Ashley Zuchner, Stephan Jordan, I. King Meller, Robert Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort |
title | Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort |
title_full | Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort |
title_fullStr | Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort |
title_full_unstemmed | Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort |
title_short | Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort |
title_sort | investigation of hypertension and type 2 diabetes as risk factors for dementia in the all of us cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672061/ https://www.ncbi.nlm.nih.gov/pubmed/36396674 http://dx.doi.org/10.1038/s41598-022-23353-z |
work_keys_str_mv | AT nagarshashwatdeepali investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT pemupriscilla investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT qianjun investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT boerwinkleeric investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT cicekmine investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT clarkcherylr investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT cohnelizabeth investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT gebokelly investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT loperenaroxana investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT mayokelsey investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT mockrinstephen investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT ohnomachadolucila investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT ramirezandreah investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT schullysheri investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT ableashley investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT greenashley investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT zuchnerstephan investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT jordaniking investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort AT mellerrobert investigationofhypertensionandtype2diabetesasriskfactorsfordementiaintheallofuscohort |